Expressing support for the designation of September 30, 2025, as "Rare Cancer Day" to highlight the challenges patients with rare cancers face and to raise awareness and support efforts to improve early diagnosis and treatment.

About 1 in 5 cancer patients in the U.S. is diagnosed with a rare cancer, and all pediatric cancers fall into this category. Rare cancers account for a quarter of all cancer deaths each year, and patients with rare cancers have lower five-year survival rates than those with more common forms. Diagnosis takes longer because symptoms are unusual and less recognizable, and treatment options are more limited because scientific understanding lags behind that of common cancers. This resolution supports designating September 30, 2025, as Rare Cancer Day and calls for more awareness, earlier detection, research partnerships, and dedicated funding.